Recursion Pharmaceuticals Acquires Full Rights to REV102, Potential Oral Therapy for Rare Bone Disorder Hypophosphatasia
Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the best small cap AI stocks to buy according to analysts.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Viking Global Andreas Halvorsen | 524,347 | $4,703,393 | 0.01% | |
| 2. | Cormorant Asset Management Bihua Chen | 400,000 | $3,588,000 | 0.18% | |
| 3. | Balyasny Asset Management Dmitry Balyasny | 376,573 | $3,377,860 | 0% | |
| 4. | Laurion Capital Management Benjamin A. Smith | 302,756 | $2,715,721 | 0.12% | |
| 5. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 300,635 | $2,696,696 | 0.1% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.80 | 200 | $2,760.00 | 926,352 | 2026-05-19 | Filing | |
| $13.98 | 10,000 | $139,822.00 | 926,152 | 2026-05-19 | Filing | |
| $13.98 | 6,009 | $83,981.18 | 916,152 | 2026-05-18 | Filing | |
| $13.95 | 200 | $2,790.00 | 910,143 | 2026-05-15 | Filing | |
| $13.80 | 100 | $1,380.00 | 909,943 | 2026-05-15 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.06 | 789 | $3,992.34 | 4,115 | 2026-02-23 | Filing | |
| $8.20 | 100,000 | $820,000.00 | 2,378,969 | 2023-03-07 | Filing | |
| $8.20 | 100,000 | $820,000.00 | 2,378,969 | 2023-03-07 | Filing | |
| $12.50 | 50,329 | $629,112.50 | 1,251,755 | 2022-06-03 | Filing | |
| $12.50 | 99,671 | $1,245,887.50 | 2,478,969 | 2022-06-03 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 793,451 | $7,117,256 | 0% | |
| 2. | 378,551 | $3,395,602 | 0.09% | |
| 3. | 300,579 | $2,696,194 | 0.96% | |
| 4. | 291,788 | $2,617,338 | 0.73% | |
| 5. | 152,901 | $1,371,522 | 0.21% |